May 10, 2025

Clinical Trials

Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer | Newswise

Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer | Newswise

David Bale06 mins

Highlights Investigational drug shows activity in anti-PD1-resistant lung cancer Targeting adenosine may enhance effectiveness of immunotherapy Favorable safety/tolerability profile observed Newswise — BUFFALO, N.Y. and CHICAGO — Patients with advanced non-small cell lung cancer (NSCLC) are often treated with immunotherapy drugs known as checkpoint inhibitors, which are designed to strengthen the immune system’s ability to…

Read More
Dual-Action Approach Targeting Inflammation Shows Potential as Type 1 Diabetes Treatment | Newswise

Dual-Action Approach Targeting Inflammation Shows Potential as Type 1 Diabetes Treatment | Newswise

David Bale07 mins

Newswise — INDIANAPOLIS — A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related protein known to drive the disease. The findings, recently published in eBioMedicine, may help inform clinical trials of a drug that is…

Read More
Mindfulness Therapy Reduces Opioid Craving and Addiction, Study Finds | Newswise

Mindfulness Therapy Reduces Opioid Craving and Addiction, Study Finds | Newswise

David Bale08 mins

Newswise — Researchers from the University of California San Diego have found that Mindfulness-Oriented Recovery Enhancement (MORE) can help rewire the brain’s response to natural healthy pleasure, leading to improved mood, greater attention to positive experiences and reduced opioid cravings. The findings, published on April 30, 2025 in the Journal of the American Medical Association…

Read More
Moffitt Cancer Center Researchers Present Top Science at AACR Annual Meeting 2025 | Newswise

Moffitt Cancer Center Researchers Present Top Science at AACR Annual Meeting 2025 | Newswise

David Bale02 mins

Newswise — TAMPA, Fla. – Researchers from Moffitt Cancer Center will present data on the latest advances in cancer science and medicine at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will take place April 25-30 in Chicago. Follow us @MoffittNews for updates. Expert InterviewsExperts from Moffitt are available to comment on a…

Read More
Managing Multiple Risk Factors Can Offset Hypertension Death Risk | Newswise

Managing Multiple Risk Factors Can Offset Hypertension Death Risk | Newswise

David Bale07 mins

Newswise — Hypertension affects over one-third of the global adult population and is a leading contributor to early death from cardiovascular and other chronic diseases. While treatments for high blood pressure are widely available, many patients still face elevated health risks due to poor management of other contributing factors, such as obesity, high cholesterol, diabetes,…

Read More
Moffitt Cancer Center Researchers Present Top Science at AACR Annual Meeting 2025 | Newswise

AACR: Topical Treatment Offers Relief From Painful Skin Rash Caused by Targeted Cancer Therapy | Newswise

David Bale07 mins

BYLINE: Denise Heady ABSTRACT CT018 FINDINGS Newswise — Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients undergoing anti-EGFR therapies…

Read More
Study: Potential Therapy for Uncontrolled Hypertension | Newswise

Study: Potential Therapy for Uncontrolled Hypertension | Newswise

David Bale06 mins

Newswise — Researchers at University of California San Diego School of Medicine identified a potential new treatment, an investigational drug called lorundrostat, for individuals with uncontrolled or treatment-resistant hypertension, commonly known as high blood pressure. The study, published in the April 23, 2025 online edition of the New England Journal of Medicine, found that clinical…

Read More
Moffitt Cancer Center Researchers Present Top Science at AACR Annual Meeting 2025 | Newswise

Evaluating the Efficacy of Stem Cells in Treating Severe Dry Eye Disease | Newswise

David Bale02 mins

Newswise — Dry eye disease (DED) is a multifactorial disorder that disturbs ocular surface equilibrium, considerably diminishing quality of life. Present therapies only offer symptomatic alleviation. Stem cell treatment, especially mesenchymal stem cells (MSCs), has surfaced as a viable approach for tissue regeneration and immunological regulation in DED. Preclinical and early clinical investigations indicate that…

Read More